Literature DB >> 3729346

Potentiating effect of pyrimethamine and sulfadoxine against dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi.

W Sirawaraporn, Y Yuthavong.   

Abstract

Dihydrofolate reductase was partially purified from a pyrimethamine-sensitive Plasmodium chabaudi clone and a pyrimethamine-resistant clone derived from it and used in a study of the inhibitory effect of pyrimethamine and sulfadoxine, both alone and in combination. Kinetic analysis of the inhibitory effect of sulfadoxine against the enzyme from pyrimethamine-sensitive and -resistant parasites revealed that the drug inhibited the former enzyme competitively, with an inhibition constant (Kis) of 0.7 +/- 0.4 mM, but inhibited the latter enzyme noncompetitively, with Kis and Kii of 8.9 +/- 1.2 and 4.1 +/- 1.2 mM, respectively. Previous studies also showed competitive inhibition by pyrimethamine on the former enzyme and noncompetitive inhibition on the latter enzyme, with some 200-fold-lower affinity. Sulfadoxine and pyrimethamine exhibited a mutually potentiating effect on the enzyme activity, as revealed by the concave isoboles and the fractional inhibitions of less than unity. A potentiating effect was observed for the enzymes from both sources and was not dependent on the degree of the purification of the enzyme. Our results can be explained by assuming simultaneous binding of two inhibitors on the enzyme.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3729346      PMCID: PMC284175          DOI: 10.1128/AAC.29.5.899

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  31 in total

1.  The characteristics and significance of sulfonamides as substrates for Escherichia coli dihydropteroate synthase.

Authors:  S Roland; R Ferone; R J Harvey; V L Styles; R W Morrison
Journal:  J Biol Chem       Date:  1979-10-25       Impact factor: 5.157

2.  Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.

Authors:  R Ferone; J J Burchall; G H Hitchings
Journal:  Mol Pharmacol       Date:  1969-01       Impact factor: 4.436

3.  Effect of substrate decomposition on the spectrophotometric assay of dihydrofolate reductase.

Authors:  B L Hillcoat; P F Nixon; R L Blakley
Journal:  Anal Biochem       Date:  1967-11       Impact factor: 3.365

Review 4.  Inhibition of folate biosynthesis and function as a basis for chemotherapy.

Authors:  G H Hitchings; J J Burchall
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1965

5.  The biosynthesis of folic acid. IX. Purification and properties of the enzymes required for the formation of dihydropteroic acid.

Authors:  D P Richey; G M Brown
Journal:  J Biol Chem       Date:  1969-03-25       Impact factor: 5.157

6.  Kinetic and molecular properties of dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi.

Authors:  W Sirawaraporn; Y Yuthavong
Journal:  Mol Biochem Parasitol       Date:  1984-03       Impact factor: 1.759

7.  A method for testing for synergy with any number of agents.

Authors:  M C Berenbaum
Journal:  J Infect Dis       Date:  1978-02       Impact factor: 5.226

8.  Plasmodium chabaudi: genetics of resistance to chloroquine.

Authors:  R A Padua
Journal:  Exp Parasitol       Date:  1981-12       Impact factor: 2.011

9.  Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro.

Authors:  J D Chulay; W M Watkins; D G Sixsmith
Journal:  Am J Trop Med Hyg       Date:  1984-05       Impact factor: 2.345

10.  Stage specific protein and nucleic acid synthesis during the asexual cycle of the rodent malaria Plasmodium chabaudi.

Authors:  C I Newbold; D B Boyle; C C Smith; K N Brown
Journal:  Mol Biochem Parasitol       Date:  1982-01       Impact factor: 1.759

View more
  1 in total

1.  Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in the dihydrofolate reductase domain.

Authors:  A Nzila-Mounda; E K Mberu; C H Sibley; C V Plowe; P A Winstanley; W M Watkins
Journal:  Antimicrob Agents Chemother       Date:  1998-01       Impact factor: 5.191

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.